Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-15-018078
Filing Date
2015-03-24
Accepted
2015-03-24 16:05:20
Documents
1
Group Members
JULIET TAMMENOMS BAKKERLONGITUDE CAPITAL ASSOCIATES, L.P.LONGITUDE VENTURE PARTNERS, L.P.PATRICK G. ENRIGHT

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v405278_sc13da2.htm SC 13D/A 116865
  Complete submission text file 0001144204-15-018078.txt   118590
Mailing Address 800 EL CAMINO REAL SUITE 220 MENLO PARK CA 94025
Business Address 800 EL CAMINO REAL SUITE 220 MENLO PARK CA 94025 650-854-5700
Longitude Capital Partners, LLC (Filed by) CIK: 0001430720 (see all company filings)

EIN.: 261165932
Type: SC 13D/A

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Subject) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87536 | Film No.: 15721727
SIC: 2834 Pharmaceutical Preparations